What is the prevalence of Eosinophilic esophagitis?
How many people does Eosinophilic esophagitis affect? Does it have the same prevalence in men and women? And in the different countries?
Eosinophilic esophagitis (EoE) is a chronic immune-mediated disorder characterized by inflammation of the esophagus. It is estimated to affect approximately 1 in 2,000 individuals in the general population, making it a relatively rare condition. EoE is more commonly diagnosed in males and often presents in childhood or early adulthood. The prevalence of EoE has been increasing over the past few decades, possibly due to improved recognition and diagnosis. Symptoms include difficulty swallowing, food impaction, and heartburn. EoE is typically managed through dietary modifications, medication, and sometimes, endoscopic dilation.
Eosinophilic esophagitis (EoE) is a chronic immune-mediated disorder characterized by inflammation of the esophagus. It is increasingly recognized as a significant cause of upper gastrointestinal symptoms and disorders. The prevalence of EoE has been steadily rising over the past few decades, although the exact numbers are still uncertain.
Studies suggest that the prevalence of EoE varies geographically, with higher rates reported in Western countries. In the United States, the estimated prevalence ranges from 1 in 2,000 to 1 in 10,000 individuals. However, recent research indicates that the prevalence may be even higher, potentially affecting up to 1 in 1,000 people.
EoE is more commonly diagnosed in males and typically presents in childhood or early adulthood. The condition is often associated with other allergic diseases, such as asthma, allergic rhinitis, and atopic dermatitis.
Accurate prevalence data is crucial for understanding the impact of EoE on public health and developing appropriate management strategies. Ongoing research aims to further investigate the prevalence and risk factors associated with this condition.
Posted Sep 29, 2020 by EOS Network (Eosinophilic Diseases Charity)
